Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data

Krista Isaac,1 Anthony R Mato2 1Division of Hematology and Oncology, University of Virginia Health System, Charlottesville, VA, USA; 2Chronic Lymphocytic Leukemia Program, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence: Krista IsaacUniversity of Virginia, PO Box 800716, Char...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Isaac K, Mato AR
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2020-03-01
coleção:	Cancer Management and Research
Assuntos:	acalabrutinib btk inhibitors cll treatment naïve cll relapsed refractory cll ibrutinib toxicity
Acesso em linha:	https://www.dovepress.com/acalabrutinib-and-its-therapeutic-potential-in-the-treatment-of-chroni-peer-reviewed-article-CMAR
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!